Iodide

Iodide

SCHEMBL9710508

I.N=C(N)c1ccc(C[C@](N)(C(=O)N2CCCCC2C(=O)O)S(=O)(=O)c2ccc3ccccc3c2)cc1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 10/20 0.51
▸ PRSS1 P07477 8/20 0.51
▸ F2 P00734 7/20 0.51
▸ PRSS2 P07478 1/20 0.49
▸ PRSS3 P35030 1/20 0.49
▸ TMPRSS15 P98073 3/20 0.43
▸ PLG P00747 2/20 0.41
▸ PLAU P00749 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8954922 0.90 F10 (0.51) F10PRSS1F2PLGPLAU
SCHEMBL8954706 0.89 F10 (0.52) F10F2PLGPLAU
SCHEMBL8954875 0.84 F10 (0.44) F10PRSS1F2PRSS2PRSS3
SCHEMBL9710628 0.83 F10 (0.53) F10PRSS1F2PRSS2PRSS3
SCHEMBL9710665 0.82 F10 (0.56) F10PRSS1F2PRSS2PRSS3
SCHEMBL8954993 0.81 CASR (0.41) F10PRSS1F2
SCHEMBL8954767 0.79 F10 (0.50) F10F2PLGPLAU
Iodide SCHEMBL8954868 0.78 F10 (0.51) F10F2PLGPLAU
Hydrochloric Acid SCHEMBL8954995 0.78 F10 (0.49) F10F2PLGPLAU
SCHEMBL9710459 0.78 F2 (0.47) F10PRSS1F2PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992016549-A1 PARASUBSTITUTED PHENYLALANINE DERIVATES PENTAPHARM AG (CH) 1992-10-01 — — WO disclosed
Send feedback